NervGen Pharma to take Case Western-developed nerve regeneration tech to market
The new technology, pioneered by researchers at Case Western Reserve School of Medicine, could improve the lives of millions of spinal cord injury patients.
from News from healthcareitnews.com https://ift.tt/2AdJlo9
0 comments:
Post a Comment